Table 5 Observed and estimated means for primary and secondary outcomes from baseline to follow-up assessment.

From: Prevention and treatment of social anxiety disorder in adolescents: mixed method randomised controlled trial of the guided online intervention SOPHIE

Measure

Condition

Baseline (observed)

Baseline (estimated)

Follow-up

(observed)

Follow-up (estimated)

  

Mean (SD)

n

Mean (SE)

n

Mean (SD)

n

Mean (SE)

n

SPIN

SOPHIE

40.32 (11.50)

66

39.80 (1.02)

66

36.43 (11.68)

42

28.11 (1.42)

66

 

CAU

39.87 (10.84)

67

39.71 (1.01)

67

37.10 (11.14)

50

35.39 (1.25)

67

SPIN

SOPHIE SAD

43.50 (9.87)

46

43.10 (1.14)

46

32.27 (13.12)

22

32.21 (1.59)

46

 

CAU SAD

42.23 (10.32)

47

42.99 (1.13)

47

34.24 (15.24)

29

35.65 (1.39)

47

SPIN

SOPHIE subclinical

33.00 (11.89)

20

32.07 (1.94)

20

15.00 (10.42)

9

17.76 (2.79)

20

 

CAU subclinical

34.30 (10.18)

20

32.52 (1.94)

20

34.33 (7.27)

12

35.20 (2.44)

20

PHQ-9

SOPHIE

12.09 (5.95)

66

11.34 (0.42)

66

9.36 (5.39)

42

8.09 (0.60)

66

 

CAU

10.66 (5.27)

67

10.99 (0.42)

67

9.16 (4.77)

50

8.57 (0.53)

67

GAD-7

SOPHIE

11.20 (4.65)

66

10.61 (0.38)

66

8.83 (4.56)

41

7.61 (0.54)

66

 

CAU

10.45 (4.24)

67

10.47 (0.37)

67

8.71 (4.30)

49

8.49 (0.47)

67

SAS-A

SOPHIE

67.86 (11.51)

66

68.76 (1.08)

66

65.05 (10.38)

40

59.66 (1.52)

66

 

CAU

70.02 (10.71)

67

69.16 (1.07)

67

68.69 (10.87)

49

63.22 (1.33)

67

KIDSSCREEN

SOPHIE

35.32 (3.71)

66

35.92 (0.42)

66

36.08 (4.47)

40

41.78 (0.60)

66

 

CAU

36.42 (3.56)

67

36.13 (0.42)

67

36.38 (4.60)

49

40.91 (0.53)

67

RSES

SOPHIE

15.79 (2.08)

66

15.78 (0.25)

66

15.93 (2.52)

40

15.68 (0.37)

66

 

CAU

15.87 (2.32)

67

15.82 (0.25)

67

15.54 (2.34)

48

15.33 (0.32)

67

GF social

SOPHIE

6.64 (1.27)

66

6.46 (0.06)

66

6.85 (1.56)

26

6.66 (0.06)

66

 

CAU

6.39 (1.26)

67

6.49 (0.09)

67

6.42 (1.42)

27

6.43 (0.11)

67

GF role

SOPHIE

6.91 (1.86)

66

7.23 (0.04)

66

6.93 (1.64)

26

6.92 (0.05)

66

 

CAU

7.12 (1.72)

67

7.19 (0.08)

67

7.31 (1.82)

27

7.07 (0.11)

67

ESAK

SOPHIE

40.92 (9.23)

61

41.12 (0.79)

61

40.20 (9.83)

54

37.64 (0.99)

66

 

CAU

41.04 (9.33)

55

41.12 (0.83)

55

40.55 (10.31)

49

38.40 (0.89)

67

  1. Notes. All linear mixed-effects models included the baseline value of investigated outcome value as a fixed covariate and a random effect of participants. SPIN = Social Phobia Inventory; SAD = diagnostic group including adolescents with a social anxiety disorder at baseline; subclinical = diagnostic group including adolescents with subclinical levels of social anxiety at baseline; PHQ-9 = 9-item version of the Patient Health Questionnaire; GAD-7: 7-item version of the Generalized Anxiety Disorder; SAS-A = Social Anxiety Scale for Adolescents; KIDSSCREEN = quality of life assessment KIDSCREEN-10; RSES = Rosenberg Self-esteem Scale; GF social: Global Functioning Scale, subscale social; GF role: Global Functioning Scale, subscale role; ESAK = Parents’ Questionnaire on Social Anxieties in Childhood and Adolescence.
Back to article page